dermatology

News

physician holds hand of a person with chronic hand eczema

LEO closes on first approval for chronic hand eczema drug

Danish dermatology specialist LEO Pharma could be just weeks away from EU approval for delgocitinib, a treatment for chronic hand eczema (CHE) considered to be its top pipeline prospect.

News

After FDA delay, Arcutis gets Zoryve OK in atopic dermatitis

After a couple of days filled with investor nervousness, Arcutis Biotherapeutics has claimed FDA approval of Zoryve for the new indication of atopic dermatitis (AD), a common form of eczema

News

Survey reveals heavy burden of chronic hand eczema

People with chronic hand eczema (CHE) have reported the serious impact the condition can have on their daily lives in a UK survey.

News

Close-up view of an actinic keratosis lesion

FDA OKs wider use of Almirall’s actinic keratosis drug

With actinic keratosis (AK) diagnoses on the rise, there is some good news for patients, with the FDA approval of expanded use of Almirall’s topical therapy Klisyri.

R&D

This week in clinical trials: 12th to 16th February 2024

In this instalment of our week-by-week clinical trials round-up, we look at life sciences research and development announced during the week of 12th to 16th February, from early-stage onwar

News

AAD: J&J’s oral IL-23 drug shows durability in psoriasis

Patients with plaque psoriasis treated with Johnson & Johnson’s oral IL-23 inhibitor JNJ-2113 have been shown to maintain skin clearance for up to a year, pointing to a durable ef

LEO closes on first approval for chronic hand eczema drug

After FDA delay, Arcutis gets Zoryve OK in atopic dermatitis

Survey reveals heavy burden of chronic hand eczema

FDA OKs wider use of Almirall’s actinic keratosis drug

This week in clinical trials: 12th to 16th February 2024

AAD: J&J’s oral IL-23 drug shows durability in psoriasis

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

dermatology

Editor's Picks